* Core Laboratories NV CLB.N reported quarterly adjusted
earnings of 8 cents per share for the quarter ended in March.
The mean expectation of ten analysts for the quarter was
for earnings of 9 cents per share.
* Revenue rose 6.4% to $115.30 million from a year ago;
analysts
expected $116.13 million.
* Core Laboratories NV's reported EPS for the quarter was a
loss
of 4 cents.
* The mean earnings estimate of analysts had fallen by
about 55.7%
in the last three months.
* In the last 30 days three analysts negatively revised
earnings
estimates
* Core Laboratories NV shares had fallen by 15.1% this
quarter and
gained 20.3% so far this year.
* The company reported a quarterly loss of $1.89 million.
* Wall Street's median 12-month price target for Core
Laboratories
NV is $28.00
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and 3 "sell" or "strong sell."
This summary was machine generated April 28 at 07:19 a.m. All
figures in US dollars unless otherwise stated